BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 12911186)

  • 1. Selective estrogen receptor modulators.
    Haskell SG
    South Med J; 2003 May; 96(5):469-76. PubMed ID: 12911186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of SERMs for treatment in postmenopausal women.
    Pinkerton JV; Thomas S
    J Steroid Biochem Mol Biol; 2014 Jul; 142():142-54. PubMed ID: 24373794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of selective estrogen receptor modulators on estrogen-sensitive tissues].
    Jirecek S; Pavo I; Huber JC
    Gynakol Geburtshilfliche Rundsch; 1999; 39(4):184-90. PubMed ID: 10629380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Selective estrogen receptor modulators (SERMs) in the practice].
    Nagykálnai T
    Magy Onkol; 2002; 46(2):165-75. PubMed ID: 12202896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial safety: a key hurdle for selective estrogen receptor modulators in development.
    Pinkerton JV; Goldstein SR
    Menopause; 2010; 17(3):642-53. PubMed ID: 20107426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.
    Riggs BL; Hartmann LC
    N Engl J Med; 2003 Feb; 348(7):618-29. PubMed ID: 12584371
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease.
    Jordan VC; Gapstur S; Morrow M
    J Natl Cancer Inst; 2001 Oct; 93(19):1449-57. PubMed ID: 11584060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on raloxifene: mechanism of action, clinical efficacy, adverse effects, and contraindications.
    Gizzo S; Saccardi C; Patrelli TS; Berretta R; Capobianco G; Di Gangi S; Vacilotto A; Bertocco A; Noventa M; Ancona E; D'Antona D; Nardelli GB
    Obstet Gynecol Surv; 2013 Jun; 68(6):467-81. PubMed ID: 23942473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raloxifene: A selective estrogen receptor modulator (SERM) with multiple target system effects.
    Muchmore DB
    Oncologist; 2000; 5(5):388-92. PubMed ID: 11040275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Specific estrogen receptor modulators (SERMs)].
    Trémollières F; Lopes P
    Presse Med; 2002 Sep; 31(28):1323-8. PubMed ID: 12355995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An alternative to postmenopausal Hormone Replacement Therapy? Selective Estrogens Receptors Modulators (SERMs)].
    Tinelli A; Perrone A; Tinelli FG
    Minerva Ginecol; 2001 Apr; 53(2):127-35. PubMed ID: 11319506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SERMs: current status and future trends.
    Morello KC; Wurz GT; DeGregorio MW
    Crit Rev Oncol Hematol; 2002 Jul; 43(1):63-76. PubMed ID: 12098608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacological review of selective oestrogen receptor modulators.
    Goldstein SR; Siddhanti S; Ciaccia AV; Plouffe L
    Hum Reprod Update; 2000; 6(3):212-24. PubMed ID: 10874566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
    Pickar JH; Komm BS
    Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of the tissue selective estrogen complex (TSEC).
    Komm BS; Mirkin S
    J Cell Physiol; 2013 Jul; 228(7):1423-7. PubMed ID: 23359290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selective estrogen-receptor modulators (SERM's) in postmenopausal women].
    Hart W; Netelenbos JC
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1771-6. PubMed ID: 10494328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raloxifene: bone and cardiovascular effects.
    Francucci CM; Romagni P; Boscaro M
    J Endocrinol Invest; 2005; 28(10 Suppl):85-9. PubMed ID: 16550730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective estrogen receptor modulators: mechanism of action and clinical experience. Focus on raloxifene.
    Thiebaud D; Secrest RJ
    Reprod Fertil Dev; 2001; 13(4):331-6. PubMed ID: 11800172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardiovascular effects of selective estrogen receptor modulators.
    Christodoulakos GE; Lambrinoudaki IV; Botsis DC
    Ann N Y Acad Sci; 2006 Dec; 1092():374-84. PubMed ID: 17308162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective estrogen receptor modulators: a new category of compounds to extend postmenopausal women's health.
    Goldstein SR
    Int J Fertil Womens Med; 1999; 44(5):221-6. PubMed ID: 10569450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.